OKT3 AND CMV DISEASE IN CADAVERIC RENAL-TRANSPLANT RECIPIENTS

被引：0
|
作者：
JOSEPHSON, M
THISTLETHWAITE, JR
STUART, J
STUART, FP
机构：
[1] UNIV CHICAGO,DEPT MED,CHICAGO,IL 60637
[2] UNIV CHICAGO,DEPT SURG,CHICAGO,IL 60637
来源：
KIDNEY INTERNATIONAL | 1990年 / 37卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：608 / 608
页数：1
相关论文
共 50 条
  • [1] MORBIDITY OF INTRAOPERATIVE OKT3 ADMINISTRATION IN PRIMARY CADAVERIC RENAL-TRANSPLANT RECIPIENTS
    KUPIN, W
    VENKAT, KK
    IKEMIYASHIRO, D
    OCDOL, H
    MOZES, M
    ANAISE, D
    JOHNSON, C
    TRANSPLANTATION PROCEEDINGS, 1993, 25 (01) : 572 - 574
  • [2] OKT3 INDUCTION IN PEDIATRIC RENAL-TRANSPLANT RECIPIENTS
    BARTOSH, SM
    THISTLETHWAITE, RJ
    ARONSON, AJ
    CLINICAL RESEARCH, 1992, 40 (02): : A388 - A388
  • [3] SELECTIVE OKT3 INDUCTION THERAPY IN ADULT CADAVERIC-DONOR RENAL-TRANSPLANT RECIPIENTS
    THISTLETHWAITE, JR
    HEFFRON, TG
    STUART, JK
    BUCKINGHAM, M
    STUART, FP
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1989, 14 (05) : 28 - 34
  • [4] EFFECT OF OKT3 ANTIBODY THERAPY ON CYTOMEGALOVIRUS REACTIVATION IN RENAL-TRANSPLANT RECIPIENTS
    CHOU, S
    NORMAN, DJ
    TRANSPLANTATION PROCEEDINGS, 1985, 17 (06) : 2755 - 2756
  • [5] OKT3 IN SEVERE EARLY REJECTION - PREDICTORS FOR REVERSAL IN RENAL-TRANSPLANT RECIPIENTS
    SUMRANI, N
    DELANEY, V
    RAJPOOT, D
    TEJANI, A
    BUTT, K
    HONG, J
    TRANSPLANTATION PROCEEDINGS, 1990, 22 (04) : 1750 - 1752
  • [6] Impact of OKT3 and polyclonal antibodies on symptomatic CMV infection in renal transplant recipients
    Yeung, S
    Tong, KL
    Chan, HWH
    TRANSPLANTATION PROCEEDINGS, 2000, 32 (07) : 1928 - 1929
  • [7] OKT3 TREATMENT INDUCES HIGHER PREVALENCE AND GREATER SEVERITY OF CYTOMEGALOVIRUS (CMV)-DISEASE IN RENAL-TRANSPLANT (RT)
    TEJADA, F
    GOMEZ, E
    AGUADO, S
    GONZALEZ, E
    MELON, S
    MARIN, R
    FERNANDEZ, F
    DEONA, M
    ALVAREZGRANDE, J
    KIDNEY INTERNATIONAL, 1994, 46 (02) : 582 - 582
  • [8] TOXICITY OF OKT3 INCREASES WITH DOSAGE - A CONTROLLED-STUDY IN RENAL-TRANSPLANT RECIPIENTS
    PARLEVLIET, KJ
    BEMELMAN, FJ
    YONG, SL
    HACK, CE
    SURACHNO, J
    WILMINK, JM
    TENBERGE, IJM
    SCHELLEKENS, PTA
    TRANSPLANT INTERNATIONAL, 1995, 8 (02) : 141 - 146
  • [9] OKT3 IN STEROID-RESISTANT RENAL-TRANSPLANT REJECTION
    RESTIFO, AC
    PETRIE, JJB
    RIGBY, RJ
    HARDIE, IR
    BURKE, JR
    ROW, PG
    STRONG, RW
    WALL, DR
    LYNCH, SV
    QUINN, JM
    WOODRUFF, PWH
    KIDNEY INTERNATIONAL, 1989, 36 (06) : 1168 - 1168
  • [10] PROPHYLACTIC USE OF OKT3 IN IMMUNOLOGICAL HIGH-RISK CADAVER RENAL-TRANSPLANT RECIPIENTS
    SCHROEDER, TJ
    FIRST, MR
    MANSOUR, ME
    ALEXANDER, JW
    PENN, I
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1989, 14 (05) : 14 - 18
12345